Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
INFORMATION: The product (substance) is neither a food product nor a dietary supplement and is not suitable for human consumption
Can Minors Get an IV
TB-4: Clinical Data for Unrelated Endpoints Meaningful human trial data for full-length TB-4 (corneal-healing Phase 2/3 as RGN-259, plus cardiac and wound-repair programs) Clean Phase 1 safety Cosmetic dosing is extrapolated from these programs Note: Full-length trial data does not transfer to the TB-500 fragment, so verify vial identity
It would be a boon to have available molecules with growth factor activity which are orally active, display profound growth factor activity, and yet are inexpensive to synthesize, for the treatment of dementia and PD
Clinical summary, 2025
Biochem Soc Trans 34 : 5963
US$ 20.02
US$ 25.92
US$ 23.32
US$ 21.78
